- Home
- RXRX vs CRGY Comparison
RXRX vs CRGY Comparison
Compare RXRX & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RXRX | CRGY |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RXRX | CRGY |
|---|---|---|
| Price | $4.12 | $8.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | $8.00 | ★ $14.10 |
| AVG Volume (30 Days) | ★ 23.4M | 5.4M |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 5.75% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $43,689,000.00 | ★ $3,590,024,000.00 |
| Revenue This Year | $6.74 | $28.94 |
| Revenue Next Year | $34.31 | $24.77 |
| P/E Ratio | ★ N/A | $80.31 |
| Revenue Growth | N/A | ★ 32.31 |
| 52 Week Low | $3.79 | $6.83 |
| 52 Week High | $12.36 | $16.94 |
Technical Indicators
Market Signals| Indicator | RXRX | CRGY |
|---|---|---|
| Relative Strength Index (RSI) | 40.30 | 42.14 |
| Support Level | $4.18 | $8.04 |
| Resistance Level | $4.43 | $8.47 |
| Average True Range (ATR) | 0.25 | 0.30 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 1.35 | 20.73 |
Price Performance
Historical ComparisonAbout RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.